A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors
NCT07208136
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
102
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
JMKX005425
Sponsor
Jemincare